🔒
This settlement's objection window has closed.
The deadline to file a formal objection has passed. This page is kept live for reference.
How It Works
Mark handles everything — this is not a DIY tool.
1
Find Your Settlement
Browse our tracked settlements and find cases where you may be a class member.
2
Submit Your Info
Tell us about your connection to the case. Takes 2 minutes. No legal knowledge required.
3
Attorney Reviews
Mark Javitch, Esq. personally evaluates your situation and determines if an objection is warranted.
4
Objection Filed
We handle all paperwork and court filing. No cost to you — attorney fees come from the settlement if successful.
In re: Roundup Products Liability Litigation (Class Settlement)
Circuit Court, City of St. Louis, Missouri
Settlement Fund
$7.3B
$7,250,000,000.00 total
Attorney Fees
$1.8B
25.0% of fund
Per Member Payout
$10,000.00
125,000 class members
Bayer (Monsanto's parent) agreed to a $7.25B settlement resolving claims by 125,000+ Roundup cancer claimants — people diagnosed with non-Hodgkin lymphoma and other cancers after exposure to glyphosate, Roundup's active ingredient. The settlement covers both current claimants and future claimants (people not yet diagnosed). Payouts are tiered from $10,000 to $165,000+ based on age, exposure, and cancer severity, structured over 21 years. The preliminary approval came March 4, 2026 from a Missouri state court. But the structural problems are severe: Federal Judge Vince Chhabria — who oversees the federal MDL — publicly called the structure "bizarre." Law firms whose more than 25 clients opt out lose their entire fee award, creating a direct financial incentive for plaintiff attorneys to discourage individual opt-outs. Bayer itself holds an escape hatch: if more than 650 plaintiffs opt out, Bayer can cancel the settlement entirely, threatening the class with no recovery at all. Future claimants — people who haven't yet been diagnosed — are asked to bind themselves to a settlement now. A Supreme Court preemption case argued April 27, 2026 could shift the entire legal landscape. Judge Chhabria rejected a nearly identical 2021 Roundup settlement for the same reasons. The opt-out deadline is June 4, 2026 — 20 days away. Final fairness hearing: July 9, 2026.
Fairness Assessment
3.0
Unfair
Red Flags
Federal judge Vince Chhabria called the settlement structure "bizarre" — not a ringing endorsement for a $7.25B deal
Punitive opt-out clause: law firms whose more than 25 clients opt out lose their fees entirely — a structural incentive to suppress objections
Bayer escape hatch: Bayer can cancel the entire settlement if more than 650 plaintiffs opt out — threatening the class into silence
Future claimants inadequately protected: settlement attempts to bind people not yet diagnosed with Roundup-linked cancer who have no current claim
Supreme Court preemption case pending (argued April 27, 2026): decision could dramatically shift Roundup liability landscape before July 9 hearing
Judge already rejected a nearly identical Roundup settlement in 2021 for the same structural fairness problems — same issues remain unresolved